Skip to main content
ARIX BIOSCIENCE PLC logo

ARIX BIOSCIENCE PLC — Investor Relations & Filings

Ticker · ARIX ISIN · GB00BD045071 LEI · 213800OVT3AHQCXNIX43 IL Financial and insurance activities
Open in API
Filings indexed 547 across all filing types
Latest filing 2021-06-14 AGM Information
Country GB United Kingdom
Listing IL ARIX

About ARIX BIOSCIENCE PLC

https://www.arixbioscience.com/

Arix Bioscience plc is a global venture capital company that specializes in the biotechnology and life sciences sectors. The firm's primary activity involves investing in and building innovative biotech companies, providing capital and strategic support from early stages, including seed, preclinical, and clinical development. Arix focuses on identifying and nurturing breakthrough advances in life sciences to accelerate the development of new medical technologies and therapies. According to public information, the company has entered into a process of liquidation.

Recent filings

Filing Released Lang Actions
Results of Annual General Meeting
AGM Information Classification · 1% confidence The document explicitly states 'Results of Annual General Meeting' in the title and body. It details that the 'Annual General Meeting (the "Meeting") was held today, Monday, 14 June 2021' and provides a table showing the results of ordinary and special resolutions passed by poll. This content directly corresponds to the definition of AGM Information, which is classified as 'AGM-R'. Although it contains voting results (DVA), the primary context is the outcome of the AGM itself, making AGM-R the most specific fit.
2021-06-14 English
Transaction in own shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states the subject matter in the title and body: "Transaction in own shares". It details the purchase of ordinary shares by Arix Bioscience plc as part of a buyback programme, including the date, volume, and price. Furthermore, the metadata section at the end explicitly lists the 'Category Code' as 'POS' and the 'OAM Categories' as '2.4. Acquisition or disposal of the issuer's own shares'. This directly corresponds to the definition for Transaction in Own Shares (Code: POS).
2021-06-11 English
Clinical portfolio update
Regulatory Filings Classification · 1% confidence The document is titled 'Clinical portfolio update' from Arix Bioscience PLC and details clinical progress updates for several portfolio companies (Imara, Harpoon, Autolus, LogicBio). It is disseminated as a 'Regulatory Announcement' via EQS Group on June 11, 2021. This type of announcement, providing operational or clinical progress updates that are material to investors but do not fit neatly into standard financial reports (like 10-K, ER, or IR), is best classified as a general Regulatory Filing (RNS). It is not a full financial report, an earnings release, a management discussion, or a proxy statement. Given the context of providing updates on portfolio activities disseminated through regulatory channels, RNS is the most appropriate general category.
2021-06-11 English
Transaction in own shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states the subject matter in the title and body: "Transaction in own shares". It details the purchase of ordinary shares as part of a buyback programme, including the number of shares purchased, prices, and the resulting total shares in issue. The metadata section also contains the category code 'POS' and the OAM Category is listed as '2.4. Acquisition or disposal of the issuer's own shares'. This directly corresponds to the definition for Transaction in Own Shares (Code: POS).
2021-06-10 English
Transaction in own shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states the subject matter in the title and body: "Transaction in own shares". It details the purchase of ordinary shares as part of a buyback programme, including the date, volume, and price. Furthermore, the metadata section at the end explicitly lists the 'Category Code' as 'POS' and the 'OAM Categories' as '2.4. Acquisition or disposal of the issuer's own shares'. This directly corresponds to the definition for Transaction in Own Shares (Code: POS).
2021-06-09 English
Transaction in own shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states the subject matter in the title and body: "Transaction in own shares". It details the purchase of ordinary shares as part of a buyback programme, including the date, volume, and price paid. Furthermore, the metadata section explicitly lists the 'Category Code' as 'POS'. This directly corresponds to the definition for 'Transaction in Own Shares' (Code: POS).
2021-06-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.